Clinical and strategic perspectives
Analyses, practical guidance and observations from work at the intersection of medicine, science, technology and business. The focus is on decisions that determine whether a healthcare innovation becomes clinically credible, operationally viable and useful in practice.
The deeper documented history of FreeStyle Libre, from oxygen dependent enzyme electrodes and osmium redox polymers to factory calibration, clinical iteration and an FDA approved treatment decision system.
Haus had attention, investors and revenue. Aperol had a repeatable ritual. What their radically different paths reveal about growth, capital, distribution and business-model fit.
Recurring startup failure patterns are often visible before they become irreversible. This article examines ten of the most common causes and what healthcare innovators can do about them.
